
Pfizer has launched a pilot delivery programme for its experimental COVID-19 vaccine in four American states, as the United States drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements.
Pfizer has launched a pilot delivery programme for its experimental COVID-19 vaccine in four American states, as the United States drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements.